Cargando…
Molecular response to aromatase inhibitor treatment in primary breast cancer
BACKGROUND: Aromatase inhibitors such as anastrozole and letrozole are highly effective suppressants of estrogen synthesis in postmenopausal women and are the most effective endocrine treatments for hormone receptor positive breast cancer in such women. Little is known of the molecular effects of th...
Autores principales: | Mackay, Alan, Urruticoechea, Ander, Dixon, J Michael, Dexter, Tim, Fenwick, Kerry, Ashworth, Alan, Drury, Suzanne, Larionov, Alexey, Young, Oliver, White, Sharon, Miller, William R, Evans, Dean B, Dowsett, Mitch |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1929101/ https://www.ncbi.nlm.nih.gov/pubmed/17555561 http://dx.doi.org/10.1186/bcr1732 |
Ejemplares similares
-
Integrative analyses identify modulators of response to neoadjuvant aromatase inhibitors in patients with early breast cancer
por: López-Knowles, Elena, et al.
Publicado: (2015) -
The effect of the stromal component of breast tumours on prediction of clinical outcome using gene expression microarray analysis
por: Cleator, Susan J, et al.
Publicado: (2006) -
Understanding the mechanisms of aromatase inhibitor resistance
por: Miller, William R, et al.
Publicado: (2012) -
Endocrinology and hormone therapy in breast cancer: Aromatase inhibitors versus antioestrogens
por: Howell, Anthony, et al.
Publicado: (2004) -
Aromatase 2004, Edinburgh, UK, 6-8 September 2004
por: Miller, William R, et al.
Publicado: (2005)